Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: A 5-year real world experience.

Mina S MakaryJonathan AlexanderLuis E RegaladoSajid JalilKhalid Mumtaz

Published in: PloS one (2024)

Based on our real world experience at a single center, DEB-TACE remains the locoregional therapy of choice for LA-HCC due to its favorable safety and efficacy profile.

Keyphrases

locally advanced
squamous cell carcinoma
rectal cancer
neoadjuvant chemotherapy
stem cells
phase ii study
decision making
cell therapy